Article | April 9, 2024

Leveraging Inductively Coupled Plasma Mass Spectrometry To Its Full Potential

Source: Alcami

By Chris Williams, Julia Spraul, and Alyssa McBurne

Liquid Chromatograph-Mass Spectrometer-GettyImages-1172199070

ICP-MS, or Inductively Coupled Plasma Mass Spectrometry, is revolutionizing the pharmaceutical industry by providing a fast and accurate method for analyzing metals in pharmaceutical products. Unlike older methods, ICP-MS can provide precise measurements within minutes, making it a superior choice for pharmaceutical companies.

Alcami, a leading provider in the industry, offers a range of ICP-MS capabilities for various applications. This includes catalyst control, assay determination, organometallic compounds, and cleaning verification. By using ICP-MS, pharmaceutical companies can monitor metal catalysts in raw materials, analyze intentional metal additions to drugs, study organometallic compounds, and verify the effectiveness of their manufacturing equipment cleaning processes.

One of the major advantages of ICP-MS is its low detection limits, which allow for the identification and quantification of trace amounts of metals. Additionally, the quick turnaround times of ICP-MS make it a valuable tool for ensuring the safety and effectiveness of pharmaceutical products. With the ability to measure multiple elements simultaneously, ICP-MS provides a comprehensive analysis of the metals present in pharmaceutical actives, raw materials, and drug products.

ICP-MS is a cutting-edge technology that is transforming the pharmaceutical industry. Its ability to provide accurate and precise measurements in a short amount of time makes it an invaluable tool for pharmaceutical companies. Alcami's range of ICP-MS capabilities further enhances the applications of this technology, allowing for catalyst control, assay determination, organometallic compound analysis, and cleaning verification. Explore how utilizing ICP-MS can help pharmaceutical companies ensure the safety and effectiveness of their products, ultimately benefiting both patients and the industry as a whole.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online